One of the directors did speak to my question at AGM re UTI, and basically they're working on that in parallel with the topical gel phase 3 trials. They just have to get gel to market ASAP to start the $ traction and promotional awareness. I sure hope this R327 is as good as it seems thus far, cause a whole lot of many millions of lives will be enhanced and even saved. It may end up being a Nobel Prize winning drug like Ivermectin that has so many uses and saved millions of lives. But hey, we're in a crazy world. Hardly anyone does carnivore diet, I'm trying it now after years of intermittent fasting and low carb success. And oh deary me, it is just almost unbelieveable. You want to be pepped up? try some of the 700+ interviews on aussie Dave's no carb life youtube channel. In a world where people can't/won't/don't do the no brainer best thing they could do, that means R327 could be better than any modern antibiotics and still not go anywhere.
I dare any of you to find someone with proveable/dependable testimony who can claim their Multiple Schlerosis did not disappear after 3mths on full carnivore diet. There's so much interesting and hope inspiring action in the metabolic therapy/nutrition space in recent times. Cancer? Well if you eliminate carbs from your diet and do glutamine blocking strategies, turns out it's very difficult for the great majority for their cancer to worsen when you cease the very food it needs to survive. Dr Thomas Seyfried.
End of rant.
- Forums
- ASX - By Stock
- RCE
- Ann: Regulatory Approval for Registrational Phase 3 R327G Trial
RCE
recce pharmaceuticals ltd
Add to My Watchlist
6.15%
!
30.5¢

Ann: Regulatory Approval for Registrational Phase 3 R327G Trial, page-33
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $87.95M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 30.5¢ | $50.06K | 159.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18840 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 5523 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18840 | 0.305 |
8 | 32432 | 0.300 |
3 | 10523 | 0.295 |
11 | 90433 | 0.290 |
2 | 135000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 5523 | 2 |
0.315 | 29444 | 2 |
0.330 | 93238 | 1 |
0.340 | 24538 | 1 |
0.350 | 30000 | 2 |
Last trade - 14.51pm 18/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online